Navigation Links
Financing of biotech companies so far in 2005: A Midwest odyssey

For a biotech company, raising money is a saga that never ends.

Just as you complete a round, you have to do two things: execute on the timely achievement of key milestones you identified for your new investors and look at the structuring of your next financing and where and who the money will come from. Most angel investors aren't repeti......

Full article >>> bove, only two of the companies had a share price above $10 per share, which is one indicator of IPO strength. Aspreva Pharmaceuticals was the only company to have a significant amount of money raised (i.e. above $75 million). So what makes for a successful IPO? It is a combination of factors including:

Market timing
Company credentials
Management team and track record
Pri......

Full article >>> s from a VC panel at the InvestMidwest conference, which was held recently in Kansas City. His remarks were in response to another west coast VC's comment that most biotech companies on the west coast are in a unique situation in that they are getting multiple term sheets for the funding of their deals. This is allowing them to pick the best deal.

Churchwell commented that the situation i......

Full article >>> illion last year (or a decline of 19 percent).

A key indicator for the Midwest biotech sector was VC activity in biotech. The first quarter showed a total of $781 million versus almost $1.4 billion last year (or a decline of 43 percent). Ouch!



Though we don't yet have data to show how the Midwest fared in this area, I'm willing to bet that it ......

Full article >>> lines.

The ramifications of the Bone Care deal are both good and bad for the Midwest. On the downside, there are only 25 publicly traded biotech companies in the Midwest. Two have been picked off this year: Orphan Medical (by Jazz Pharmaceuticals) and now Bone Care (also don't forget Esperion and Cima Labs in 2003).

On the positive side, there are some new multi-millionaire inves......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 05/11/05


Related biology technology :

1. Financing life science: The ongoing saga
2. Seed-Stage Venture Financing
3. Quintessence Secures Financing
4. The state of global biotech: An Ernst & Young perspective
5. Olympics of biotechnology has international flavor
6. Getting noticed in Genetown: Wisconsin biotech on display
7. Madison biotech NimbleGen files for IPO; one of states best-funded firms
8. Wisconsin biotech firm receives $107K NIH grant
9. Manufacturing partnership will move into biotech and biomedical spaces
10. Wisconsin wont get Georgia biotech without a fight
11. The 10 biggest events shaping biotech in 2006
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... The Fight Against Cancer Innovation Trust (FACIT) and the ... report that Fusion Pharmaceuticals Inc. (Fusion) has closed a ... – JJDC, Inc. (JJDC) as the lead investor. Additional, ... and Genesys Capital, as well as founding investor FACIT.  ... ...
(Date:2/23/2017)... , Feb. 23, 2017  In Atlanta, it seems ... fashion, and culture intertwine to create an expressive and dynamic ... reflect this energy and contribute to it. ... Hair Fairies seeks to carry on that tradition ... Atlanta salon is the newest of ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... that in a published evaluation of multiple immunoassay-based threat detection technologies by ... Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have ...
Breaking Biology Technology:
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
(Date:2/3/2017)... Feb. 3, 2017 A new independent identity ... Partners, LLP (IdSP) . Designed to fill a critical ... identity market, founding partners Mark Crego and ... years just in identity expertise that span federal governments, ... leadership. The Crego-Kephart combined expertise has a common theme ...
(Date:1/31/2017)... CAMBRIDGE, Mass. , Jan. 31, 2017 /PRNewswire-USNewswire/ ... develop novel therapies for the treatment of bacterial ... generation set of antibacterial candidates from Pro Bono ... the increased prevalence of multi-drug resistant forms of ... by Cantab Anti Infectives Ltd, a PBB group ...
Breaking Biology News(10 mins):